An unexpected error occurred: 
      

How Rising GLP-1 Use is Affecting Food Packaging

While consumer appetites and spending decrease, food companies must use innovation to stand out on the shelf.

Diana Courtepatte, Director of Marketing, TC Transcontinental Packaging, spoke with Dr. Tiffany Dzugan, ND, Healing Roots Chiropractic and Wellness Centre, Stephanie Mattucci, CFS - Principal Strategist, Food Science, Mintel, and Tim Kieny, VP of Sales & Marketing, TC Transcontinental Packaging. The live session was titled, “Rethinking Food in the GLP-1 Era: How appetites, spend, and pack sizes are shifting, and what brands should do now.”
Diana Courtepatte, Director of Marketing, TC Transcontinental Packaging, spoke with Dr. Tiffany Dzugan, ND, Healing Roots Chiropractic and Wellness Centre, Stephanie Mattucci, CFS - Principal Strategist, Food Science, Mintel, and Tim Kieny, VP of Sales & Marketing, TC Transcontinental Packaging. The live session was titled, “Rethinking Food in the GLP-1 Era: How appetites, spend, and pack sizes are shifting, and what brands should do now.”
PMMI Media Group/ TC Transcontinental

There’s likely not a day that goes by that you won’t see something about a GLP-1 drug via a television commercial, a celebrity getting slammed on social media, or even brought up by a friend over dinner. The use of the drug is exploding for weight loss (and diabetes), and the food industry is noticing the shift in trends.

To address this head-on, TC Transcontinental Packaging hosted a recent Linkedin Live on the topic of GLP-1s and how the rise in the drug use is impacting consumer appetite, spend, and as such, packaging sizes.

Diana Courtepatte, Director of Marketing, TC Transcontinental Packaging, spoke with Dr. Tiffany Dzugan, ND, Healing Roots Chiropractic and Wellness Centre, Stephanie Mattucci, CFS - Principal Strategist, Food Science, Mintel, and Tim Kieny, VP of Sales & Marketing, TC Transcontinental Packaging. The live session was titled, “Rethinking Food in the GLP-1 Era: How appetites, spend, and pack sizes are shifting, and what brands should do now.”

How GLP-1 is changing consumer behavior

Not surprising, GLP-1s are a huge force in the pharmaceutical industry. TC Transcontinental Packaging reports that 45% of U.S. adults are using, have used, or have expressed interest in GLP-1s. And as such, this use is changing how Americans eat and shop. Most notably, the company reports that overall household food spending has dropped by 6-11%.

“We are officially in the GLP-1 era,” says Stephanie Mattucci, CFS, Principal Strategist, Food Science at Mintel. “Obesity rates are leveling off and are dipping for the first time in over a decade, and weight loss medication could be part of that reason.”

Mintel data shows that GLP-1 use is climbing fast, with 18% of consumers using them in 2025, up from 12% in 2024. And industry experts like Mattucci predict that more people will jump on board.

“Advancements with pill versions, generics on the horizon, better access, lower cost…. more growth is inevitable,” says Mattucci.

While attention in the media is on the weight loss side of the drug, GLP-1s remain an important drug for diabetes treatment. In fact, the World Health Organization (WHO) has added GLP-1s to the list of critical medicines for diabetes treatment.

While 18% of consumers using a GLP-1 may seem low, Mattucci points out that 82% of Americans are managing their weight in some way, so food labeling and packaging that speaks to this trend is a must. Early studies reveal that GLP-1 users spend less on food, especially indulgent items like potato chips and sweets. Instead, the industry is seeing an increase in demand for nutrient-rich foods, like fruit, vegetables, and high-protein categories.

        An unexpected error occurred: